These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 30551451)
21. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. Ma X; Wei J; Zhang L; Deng D; Liu L; Mei X; He X; Tian J Biomed Pharmacother; 2016 May; 80():220-226. PubMed ID: 27133060 [TBL] [Abstract][Full Text] [Related]
22. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer. Wang Z; Qu H; Gong W; Liu A IUBMB Life; 2018 Nov; 70(11):1164-1176. PubMed ID: 30281914 [TBL] [Abstract][Full Text] [Related]
23. E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle. Sun J; Shi R; Zhao S; Li X; Lu S; Bu H; Ma X; Su C J Exp Clin Cancer Res; 2017 Mar; 36(1):40. PubMed ID: 28270228 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma. Wang Z; Zhang H; Zhang P; Dong W; He L Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649 [TBL] [Abstract][Full Text] [Related]
25. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
26. Micro-RNA-451 Reduces Proliferation of B-CPAP Human Papillary Thyroid Cancer Cells by Downregulating Expression of Activating Transcription Factor 2. Zhang MF; Fei ZW; Huang L Med Sci Monit; 2021 Mar; 27():e929774. PubMed ID: 33724979 [TBL] [Abstract][Full Text] [Related]
27. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845 [TBL] [Abstract][Full Text] [Related]
28. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6. Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of microR-147b represses the proliferation and invasion of thyroid carcinoma cells by inhibiting Wnt/β-catenin signaling via targeting SOX15. Xu C; Liu J; Yao X; Bai Y; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Guo L; Zheng Z; Zhang S Mol Cell Endocrinol; 2020 Feb; 501():110662. PubMed ID: 31760045 [TBL] [Abstract][Full Text] [Related]
30. MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12. Dong S; Jin M; Li Y; Ren P; Liu J Oncol Rep; 2016 Apr; 35(4):2151-8. PubMed ID: 26847706 [TBL] [Abstract][Full Text] [Related]
31. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression. Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202 [TBL] [Abstract][Full Text] [Related]
33. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1. Yin JJ; Cheng XY Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097 [TBL] [Abstract][Full Text] [Related]
35. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1. Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400 [TBL] [Abstract][Full Text] [Related]
36. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway. Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303 [TBL] [Abstract][Full Text] [Related]
37. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512 [TBL] [Abstract][Full Text] [Related]
38. The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells. Yao C; Ruan JW; Zhu YR; Liu F; Wu HM; Zhang Y; Jiang Q Aging (Albany NY); 2020 Mar; 12(6):5399-5410. PubMed ID: 32203055 [TBL] [Abstract][Full Text] [Related]
39. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α. Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566 [TBL] [Abstract][Full Text] [Related]
40. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma. Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]